The University of Southampton
University of Southampton Institutional Repository

Antagonistic human FcyRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo

Antagonistic human FcyRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo
Antagonistic human FcyRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo
Therapeutic antibodies have transformed cancer therapy, unlocking mechanisms of action by engaging the immune system. Unfortunately, cures rarely occur and patients display intrinsic or acquired resistance. Here, we demonstrate the therapeutic potential of targeting human (h) Fc?RIIB (CD32B), a receptor implicated in immune cell desensitization and tumor cell resistance. Fc?RIIB-blocking antibodies prevented internalization of the CD20-specific antibody rituximab, thereby maximizing cell surface accessibility and immune effector cell mediated antitumor activity. In hFc?RIIB-transgenic (Tg) mice, Fc?RIIB-blocking antibodies effectively deleted target cells in combination with rituximab, and other therapeutic antibodies, from resistance-prone stromal compartments. Similar efficacy was seen in primary human tumor xenografts, including with cells from patients with relapsed/refractory disease. These data support the further development of hFc?RIIB antibodies for clinical assessment.
1535-6108
473-488
Roghanian, Ali
e2b032c2-60a0-4522-a3d8-56a768792f36
Teige, Ingrid
c6bf25bd-f182-46ab-9b8e-bd0159a4544b
Mårtensson, Linda
93e7b5b8-f383-4ec2-974d-0ede8832aef8
Cox, Kerry L.
7305c27e-9cdc-4e37-b994-ac55d7d1dfd2
Kovacek, Mathilda
74fc1b30-36e4-424a-9048-f9020a059f34
Ljungars, Anne
ebf11d2f-1786-4221-bc28-32c0ba09d805
Mattson, Jenny
112b2e15-73b1-4b6a-859f-3611cc81c282
Sundberg, Annika
68d8646d-9211-41d7-95f3-420efa2d362b
Vaughan, Andrew T.
bfb2ceab-a592-457e-89f9-00fcd1dddbdb
Shah, Vallari
90cbb755-87d0-454f-891b-13b4ed9d0d29
Smyth, Neil R.
0eba2a40-3b43-4d40-bb64-621bd7e9d505
Sheth, Bhavwanti
c79e4e33-b1ea-4ca7-a0f5-def1c7adf44c
Chan, H.T. Claude
b109c93f-7e9a-44ee-ad12-da757b1b11fc
Li, Zhan-Chun
735ac2b7-c9f2-4e83-8220-281490129c13
Williams, Emily L.
f2650481-4f32-470a-b7fb-c78f026de16c
Manfredi, Giusi
700ada58-fffa-413a-8a77-564b46e08801
Oldham, Robert J.
f43d1416-0b93-4dfd-a504-2850cb43e87e
Mockridge, C. Ian
327aef17-4837-4f2a-a93b-3d17cd1a7f9f
James, Sonya A.
764c80e3-5bea-4b34-a871-b43f87ef97b0
Dahal, Lekh N.
1e993a7a-b007-4187-82ea-e28dd3920b66
Hussain, Khiyam
9468f252-81d0-4251-b800-702433b610f8
Nilsson, Björn
829b06d9-f6cc-4099-b591-1aefbed24c4c
Verbeek, J. Sjef
115ffb7c-4760-444f-888c-0798469e0b9c
Juliusson, Gunnar
6abe77cf-d2a4-40bd-871a-c9730479c6b5
Hansson, Markus
3a07d8dc-a96f-4418-8278-35f358806235
Jerkeman, Mats
52d57011-f86b-4986-a607-998b628d074a
Johnson, Peter W.M.
3f6068ce-171e-4c2c-aca9-dc9b6a37413f
Davies, Andrew
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Beers, Stephen A.
a02548be-3ffd-41ab-9db8-d6e8c3b499a2
Glennie, Martin J.
9f6f0eff-4560-48c2-80cd-0ec116110ded
Frendéus, Björn
ea6161a4-2041-4317-9802-95f623219fa6
Cragg, Mark S.
ec97f80e-f3c8-49b7-a960-20dff648b78c
Roghanian, Ali
e2b032c2-60a0-4522-a3d8-56a768792f36
Teige, Ingrid
c6bf25bd-f182-46ab-9b8e-bd0159a4544b
Mårtensson, Linda
93e7b5b8-f383-4ec2-974d-0ede8832aef8
Cox, Kerry L.
7305c27e-9cdc-4e37-b994-ac55d7d1dfd2
Kovacek, Mathilda
74fc1b30-36e4-424a-9048-f9020a059f34
Ljungars, Anne
ebf11d2f-1786-4221-bc28-32c0ba09d805
Mattson, Jenny
112b2e15-73b1-4b6a-859f-3611cc81c282
Sundberg, Annika
68d8646d-9211-41d7-95f3-420efa2d362b
Vaughan, Andrew T.
bfb2ceab-a592-457e-89f9-00fcd1dddbdb
Shah, Vallari
90cbb755-87d0-454f-891b-13b4ed9d0d29
Smyth, Neil R.
0eba2a40-3b43-4d40-bb64-621bd7e9d505
Sheth, Bhavwanti
c79e4e33-b1ea-4ca7-a0f5-def1c7adf44c
Chan, H.T. Claude
b109c93f-7e9a-44ee-ad12-da757b1b11fc
Li, Zhan-Chun
735ac2b7-c9f2-4e83-8220-281490129c13
Williams, Emily L.
f2650481-4f32-470a-b7fb-c78f026de16c
Manfredi, Giusi
700ada58-fffa-413a-8a77-564b46e08801
Oldham, Robert J.
f43d1416-0b93-4dfd-a504-2850cb43e87e
Mockridge, C. Ian
327aef17-4837-4f2a-a93b-3d17cd1a7f9f
James, Sonya A.
764c80e3-5bea-4b34-a871-b43f87ef97b0
Dahal, Lekh N.
1e993a7a-b007-4187-82ea-e28dd3920b66
Hussain, Khiyam
9468f252-81d0-4251-b800-702433b610f8
Nilsson, Björn
829b06d9-f6cc-4099-b591-1aefbed24c4c
Verbeek, J. Sjef
115ffb7c-4760-444f-888c-0798469e0b9c
Juliusson, Gunnar
6abe77cf-d2a4-40bd-871a-c9730479c6b5
Hansson, Markus
3a07d8dc-a96f-4418-8278-35f358806235
Jerkeman, Mats
52d57011-f86b-4986-a607-998b628d074a
Johnson, Peter W.M.
3f6068ce-171e-4c2c-aca9-dc9b6a37413f
Davies, Andrew
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Beers, Stephen A.
a02548be-3ffd-41ab-9db8-d6e8c3b499a2
Glennie, Martin J.
9f6f0eff-4560-48c2-80cd-0ec116110ded
Frendéus, Björn
ea6161a4-2041-4317-9802-95f623219fa6
Cragg, Mark S.
ec97f80e-f3c8-49b7-a960-20dff648b78c

Roghanian, Ali, Teige, Ingrid, Mårtensson, Linda, Cox, Kerry L., Kovacek, Mathilda, Ljungars, Anne, Mattson, Jenny, Sundberg, Annika, Vaughan, Andrew T., Shah, Vallari, Smyth, Neil R., Sheth, Bhavwanti, Chan, H.T. Claude, Li, Zhan-Chun, Williams, Emily L., Manfredi, Giusi, Oldham, Robert J., Mockridge, C. Ian, James, Sonya A., Dahal, Lekh N., Hussain, Khiyam, Nilsson, Björn, Verbeek, J. Sjef, Juliusson, Gunnar, Hansson, Markus, Jerkeman, Mats, Johnson, Peter W.M., Davies, Andrew, Beers, Stephen A., Glennie, Martin J., Frendéus, Björn and Cragg, Mark S. (2015) Antagonistic human FcyRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo. Cancer Cell, 27 (4), 473-488. (doi:10.1016/j.ccell.2015.03.005). (PMID:25873171)

Record type: Article

Abstract

Therapeutic antibodies have transformed cancer therapy, unlocking mechanisms of action by engaging the immune system. Unfortunately, cures rarely occur and patients display intrinsic or acquired resistance. Here, we demonstrate the therapeutic potential of targeting human (h) Fc?RIIB (CD32B), a receptor implicated in immune cell desensitization and tumor cell resistance. Fc?RIIB-blocking antibodies prevented internalization of the CD20-specific antibody rituximab, thereby maximizing cell surface accessibility and immune effector cell mediated antitumor activity. In hFc?RIIB-transgenic (Tg) mice, Fc?RIIB-blocking antibodies effectively deleted target cells in combination with rituximab, and other therapeutic antibodies, from resistance-prone stromal compartments. Similar efficacy was seen in primary human tumor xenografts, including with cells from patients with relapsed/refractory disease. These data support the further development of hFc?RIIB antibodies for clinical assessment.

Text
1-s2.0-S1535610815000938-main - Version of Record
Available under License Other.
Download (5MB)

More information

Accepted/In Press date: 10 March 2015
e-pub ahead of print date: 13 April 2015
Published date: 13 April 2015
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 376434
URI: http://eprints.soton.ac.uk/id/eprint/376434
ISSN: 1535-6108
PURE UUID: fef8fb1a-34fe-4a31-ba03-632273d841f2
ORCID for Ali Roghanian: ORCID iD orcid.org/0000-0003-1316-4218
ORCID for Andrew T. Vaughan: ORCID iD orcid.org/0000-0001-6076-3649
ORCID for H.T. Claude Chan: ORCID iD orcid.org/0000-0003-0530-9480
ORCID for Peter W.M. Johnson: ORCID iD orcid.org/0000-0003-2306-4974
ORCID for Andrew Davies: ORCID iD orcid.org/0000-0002-7517-6938
ORCID for Stephen A. Beers: ORCID iD orcid.org/0000-0002-3765-3342
ORCID for Mark S. Cragg: ORCID iD orcid.org/0000-0003-2077-089X

Catalogue record

Date deposited: 28 Apr 2015 12:51
Last modified: 15 Mar 2024 03:34

Export record

Altmetrics

Contributors

Author: Ali Roghanian ORCID iD
Author: Ingrid Teige
Author: Linda Mårtensson
Author: Kerry L. Cox
Author: Mathilda Kovacek
Author: Anne Ljungars
Author: Jenny Mattson
Author: Annika Sundberg
Author: Andrew T. Vaughan ORCID iD
Author: Vallari Shah
Author: Neil R. Smyth
Author: Bhavwanti Sheth
Author: H.T. Claude Chan ORCID iD
Author: Zhan-Chun Li
Author: Emily L. Williams
Author: Giusi Manfredi
Author: Robert J. Oldham
Author: C. Ian Mockridge
Author: Sonya A. James
Author: Lekh N. Dahal
Author: Khiyam Hussain
Author: Björn Nilsson
Author: J. Sjef Verbeek
Author: Gunnar Juliusson
Author: Markus Hansson
Author: Mats Jerkeman
Author: Andrew Davies ORCID iD
Author: Björn Frendéus
Author: Mark S. Cragg ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×